MimiVax's Series A Round

MimiVax raised a round of funding on August 25, 2015. Investors include Buffalo Capital Partners.

MimiVax is commercializing intellectual property developed at Roswell Park Cancer Institute (RPCI) through bench to bedside clinical translation. The company is developing immunotherapeutic vaccines a…

Articles about MimiVax's Series A Round: